Provincial drug plans adding new lymphoma treatment is good news for patients, but other promising cancer therapies still awaiting green light Press Releases Provincial drug plans adding new lymphoma treatment is good news for patients, but other promising cancer therapies still awaiting green light
Lymphoma Foundation Canada announces name change and launch of new brand Press Releases Lymphoma Foundation Canada announces name change and launch of new brand
Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL) Research Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL)
Lymphoma Action Symposium with Richard Petit Press Releases Lymphoma Action Symposium with Richard Petit
BC Cancer Agency Scientists Unlock Lymphoma Clues Research BC Cancer Agency Scientists Unlock Lymphoma Clues